India to Canada: Temozolomide Export Trade Route
India has recorded 47 verified shipments of Temozolomide exported to Canada, representing a combined trade value of $7.5M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $158.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 61% of total export value with 22 shipments worth $4.6M USD. On the buying side, TARO PHARMACEUTICALS INC., is the largest importer in Canada with $3.0M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Temozolomide corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $7.5M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 61% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $158.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 21.1%, placing it at rank #5 among India's top temozolomide export destinations globally.
On the import side, key buyers of Indian temozolomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC and 8 others. TARO PHARMACEUTICALS INC., is the single largest importer with 12 shipments valued at $3.0M USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ2
- Primary modeSea freight
- Top portDELHI AIR
Market Position
- Global rank#5
- Annual growth+21.1%
- Demand growth+19.8%
- Regulatory ease79/100
Top 10 Indian Temozolomide Exporters to Canada
Showing top 10 of 5 Indian suppliers exporting Temozolomide to Canada, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $208.6K per shipment | 22 | $4.6M | 61.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $468.5K per shipment | 3 | $1.4M | 18.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $336.7K per shipment | 3 | $1.0M | 13.5% |
| 4 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $25.1K per shipment | 18 | $451.7K | 6.0% |
| 5 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $11.6K per shipment | 1 | $11.6K | 0.2% |
This table shows the top 10 of 5 Indian companies exporting temozolomide to Canada, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD, RELIANCE LIFE SCIENCES PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED . SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 22 shipments worth $4.6M USD, giving it a 61% market share. The top 3 suppliers together account for 94% of the total trade value on this route.
Top 10 Temozolomide Importers in Canada
Showing top 10 of 11 known buyers in Canada receiving Temozolomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian temozolomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC., JAMP PHARMA CORP, among 11 total buyers. The largest importer is TARO PHARMACEUTICALS INC.,, accounting for $3.0M USD across 12 shipments — representing 41% of all temozolomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO PHARMACEUTICALS INC., | 12 | $3.0M | 40.7% |
| 2 | TARO PHARMACEUTICALS INC | 7 | $1.6M | 21.2% |
| 3 | TARO PHARMACEUTICALS INC | 2 | $1.1M | 14.8% |
| 4 | TARO PHARMACEUTICALS INC. | 5 | $760.9K | 10.2% |
| 5 | JAMP PHARMA CORP | 12 | $321.0K | 4.3% |
| 6 | M/S. TARO PHARMACEUTICALS INC | 1 | $298.5K | 4.0% |
| 7 | M S TARO PHARMACEUTICALS INC | 1 | $214.2K | 2.9% |
| 8 | JAMP PHARMA CORP, | 3 | $108.2K | 1.4% |
| 9 | JAMP PHARMA CORPORATION | 2 | $20.2K | 0.3% |
| 10 | JAMP PHARMA CORP. | 1 | $11.6K | 0.2% |
Showing top 10 of 11 Temozolomide importers in Canada on this route.
Top 10 Temozolomide Formulations Imported by Canada
Showing top 10 of 38 product formulations shipped on the India to Canada Temozolomide route, ranked by trade value
Canada imports a wide range of temozolomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5] BATCH NO. HAF0558A & HAF0559A MFG. DT. 02/2024 EXP. DT. 01/2026 — accounts for $2.1M USD across 3 shipments. There are 38 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO-TEMOZOLOMIDE 100MG CAPSULES [16414PACK X 1X5] BATCH NO. HAF0558A & HAF0559A MFG. DT. 02/2024 EXP. DT. 01/2026 | 3 | $2.1M | 27.5% |
| 2 | TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH : | 1 | $998.9K | 13.4% |
| 3 | TARO-TEMOZOLOMIDE 140 MG CAPSULE PACK :01*05 Batch No. As Per DOCUMENT | 1 | $775.8K | 10.4% |
| 4 | TARO-TEMOZOLOMIDE 140MG CAPSULES [8307 PACK X 1X5] BATCH NO. HAF0730A & HAF0731AMFG DT: 03/2024 EXP DT: 02/2026 | 3 | $635.6K | 8.5% |
| 5 | TARO-TEMOZOLOMIDE 100 MG CAPSULE PACK :01*05 BATCH DETAILS AS PER DOCUMENT | 1 | $306.4K | 4.1% |
| 6 | TARO-TEMOZOLOMIDE 100 MG CAPSULE PACK: 0 | 1 | $298.5K | 4.0% |
| 7 | TARO-TEMOZOLOMIDE 100MG CAPSULES [2299 PACK X 1X5'S]NOS | 1 | $288.2K | 3.9% |
| 8 | TARO-TEMOZOLOMIDE 20MG CAPSULE PACK:01*05 BATCH:HAE1608A | 1 | $214.2K | 2.9% |
| 9 | TARO-TEMOZOLOMIDE 140 MG CAPSULE BATCH : | 1 | $210.3K | 2.8% |
| 10 | TARO-TEMOZOLOMIDE 20MG CAPSULES [8050 PACK X 1X5] BATCH NO. HAF0556A MFG. DT. 03/2024 EXP. DT. 02/2026 | 3 | $203.2K | 2.7% |
Showing top 10 of 38 Temozolomide formulations imported by Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR handles the highest volume with 16 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's temozolomide exports to Canada are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD — together account for 94% of total trade value on this route. The average shipment value of $158.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as taro-temozolomide 140 mg capsule batch : and taro-temozolomide 140 mg capsule pack :01*05 batch no. as per document , suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TARO PHARMACEUTICALS INC., is the largest importer with 12 shipments worth $3.0M USD — representing 41% of all temozolomide imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $7.5M
- Avg. Shipment
- $158.9K
- Suppliers
- 5
- Buyers
- 11
- Transit (Sea)
- ~22 days
- Annual Growth
- +21.1%
Related Analysis
Other Temozolomide Routes
Unlock the Full India to Canada Temozolomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 47 shipments on this route.
Frequently Asked Questions — India to Canada Temozolomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Temozolomide to Canada?
The leading Indian exporters of Temozolomide to Canada are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , SUN PHARMACEUTICAL INDUSTRIES LTD. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 61% of total trade value on this route.
Q What is the total value of Temozolomide exports from India to Canada?
India exports Temozolomide to Canada worth approximately $7.5M USD across 47 recorded shipments. The average value per shipment is $158.9K USD.
Q Which ports does India use to ship Temozolomide to Canada?
The most active port of origin is DELHI AIR with 16 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Canada for Temozolomide?
The average transit time for Temozolomide shipments from India to Canada is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Canada Temozolomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.1% with demand growth tracking at 19.8%. The route is ranked #5 among India's top Temozolomide export destinations globally.
Q How many suppliers are active on the India to Canada Temozolomide route?
There are currently 5 active Indian suppliers exporting Temozolomide to Canada. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 61% of total shipment value.
Q Who are the main importers of Temozolomide from India in Canada?
The leading importers of Indian Temozolomide in Canada include TARO PHARMACEUTICALS INC.,, TARO PHARMACEUTICALS INC, TARO PHARMACEUTICALS INC , TARO PHARMACEUTICALS INC., JAMP PHARMA CORP. TARO PHARMACEUTICALS INC., is the largest buyer with 12 shipments worth $3.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Temozolomide.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 11 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 47 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
47 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists